Schiffer D - Search Results

1

SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.

Mellai M, Cattaneo M, Storaci AM, Annovazzi L, Cassoni P, Melcarne A, De Blasio P, Schiffer D, Biunno I. Mellai M, et al. Among authors: schiffer d. Oncotarget. 2015 May 20;6(14):12452-67. doi: 10.18632/oncotarget.3611. Oncotarget. 2015. PMID: 25948789 Free PMC article.

2

The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment.

Annovazzi L, Caldera V, Mellai M, Riganti C, Battaglia L, Chirio D, Melcarne A, Schiffer D. Annovazzi L, et al. Among authors: schiffer d. Int J Oncol. 2015;46(6):2299-308. doi: 10.3892/ijo.2015.2963. Epub 2015 Apr 16. Int J Oncol. 2015. PMID: 25892134 Free PMC article.

3

Comparison among conventional and advanced MRI, ¹⁸F-FDG PET/CT, phenotype and genotype in glioblastoma.

Valentini MC, Mellai M, Annovazzi L, Melcarne A, Denysenko T, Cassoni P, Casalone C, Maurella C, Grifoni S, Fania P, Cistaro A, Schiffer D. Valentini MC, et al. Among authors: schiffer d. Oncotarget. 2017 Oct 4;8(53):91636-91653. doi: 10.18632/oncotarget.21482. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207673 Free PMC article.

4

Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.

Mellai M, Cattaneo M, Storaci AM, Annovazzi L, Cassoni P, Melcarne A, De Blasio P, Schiffer D, Biunno I. Mellai M, et al. Among authors: schiffer d. Oncotarget. 2018 Aug 24;9(66):32731. doi: 10.18632/oncotarget.26066. eCollection 2018 Aug 24. Oncotarget. 2018. PMID: 30220979 Free PMC article.

5

SEL1L plays a major role in human malignant gliomas.

Mellai M, Annovazzi L, Boldorini R, Bertero L, Cassoni P, De Blasio P, Biunno I, Schiffer D. Mellai M, et al. Among authors: schiffer d. J Pathol Clin Res. 2020 Jan;6(1):17-29. doi: 10.1002/cjp2.134. Epub 2019 Sep 30. J Pathol Clin Res. 2020. PMID: 31111685 Free PMC article.

6

MGMT promoter hypermethylation in a series of 104 glioblastomas.

Mellai M, Caldera V, Annovazzi L, Chiò A, Lanotte M, Cassoni P, Finocchiaro G, Schiffer D. Mellai M, et al. Among authors: schiffer d. Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):219-27. Cancer Genomics Proteomics. 2009. PMID: 19656999 Free article.

7

SOX2 expression and amplification in gliomas and glioma cell lines.

Annovazzi L, Mellai M, Caldera V, Valente G, Schiffer D. Annovazzi L, et al. Among authors: schiffer d. Cancer Genomics Proteomics. 2011 May-Jun;8(3):139-47. Cancer Genomics Proteomics. 2011. PMID: 21518820

8

MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors.

Mellai M, Monzeglio O, Piazzi A, Caldera V, Annovazzi L, Cassoni P, Valente G, Cordera S, Mocellini C, Schiffer D. Mellai M, et al. Among authors: schiffer d. J Neurooncol. 2012 May;107(3):617-31. doi: 10.1007/s11060-011-0787-y. J Neurooncol. 2012. PMID: 22287028

9

MGMT hypermethylation and MDR system in glioblastoma cancer stem cells.

Caldera V, Mellai M, Annovazzi L, Monzeglio O, Piazzi A, Schiffer D. Caldera V, et al. Among authors: schiffer d. Cancer Genomics Proteomics. 2012 Jul-Aug;9(4):171-8. Cancer Genomics Proteomics. 2012. PMID: 22798502

10

Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.

Mellai M, Piazzi A, Caldera V, Annovazzi L, Monzeglio O, Senetta R, Cassoni P, Schiffer D. Mellai M, et al. Among authors: schiffer d. Biomed Res Int. 2013;2013:756302. doi: 10.1155/2013/756302. Epub 2013 Sep 3. Biomed Res Int. 2013. PMID: 24083241 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

383 results

Search Page

Filters